NURS 8210 Week 7 Data Stewardship Analysis Paper Example

Course	NURS 8210 Transforming Nursing and Healthcare Through Technology
Week	Week 7
Paper type	Data stewardship analysis
Length	About 1,160 words, 7 pages
Format	APA 7 student paper
School	Walden University
Program	Doctor of Nursing Practice (DNP)
Updated	September 2026

Free sample paper for NURS 8210 Week 7

Before the Extract Leaves: A Data Stewardship Analysis of Pooling Home Monitoring Readings With the Record for a Vendor's Deterioration Model

Student Name

College of Nursing, Walden University

NURS 8210: Transforming Nursing and Healthcare Through Technology

Instructor Name

Month Day, Year

What this page is doingThe title places the analysis at the moment of decision, before data leave the organization, and names what is being pooled and for whom.

Before the Extract Leaves: A Data Stewardship Analysis of Pooling Home Monitoring Readings With the Record for a Vendor's Deterioration Model

The Decision

An organization with more data than governance usually discovers the gap during a vendor negotiation. A composite integrated health system, with four hospitals, a home health agency and a remote monitoring program for adults with heart failure and COPD, has been approached by a vendor that wants to build a model predicting deterioration at home. The vendor asks for an extract that joins two years of home monitoring readings, such as weight, oxygen saturation, heart rate and symptom scores, with record data on diagnoses, medications, admissions and deaths. In return, the system would receive early access to the model and a discount on its license.

The executive team must decide whether to share the extract, and on what terms. This analysis does not answer that question directly. It sets out who in the organization may decide, what the data are, what patients were told, what the law requires and what it leaves open, and who will answer if the model is wrong. The decision the team makes should follow from those answers, not from the attractiveness of the discount.

A Stewardship Map

Data governance work distinguishes decision rights, who may decide what about data, from the technical work of managing them (Khatri & Brown, 2010). At present the system blurs the two. The remote monitoring program's manager controls the monitoring platform, the informatics team controls the record's data warehouse and the vendor relationship is being handled by business development. No one is clearly responsible for the joined data set, which does not yet exist. Table 1 proposes a map.

Table 1

Proposed Stewardship Roles for the Joined Monitoring and Record Data

Role	Position	May decide alone	Must refer upward
Executive owner	Chief nursing officer, as executive sponsor of remote monitoring	Whether the joined data set is created for internal use	Any sharing outside the organization
Data steward	Director of nursing informatics	Definitions, quality rules and internal access requests	Requests from outside parties or for new purposes
Technical custodian	Data warehouse manager	Storage, security controls and extraction methods	Any change in who can see identified data
Privacy review	Privacy officer with the data governance committee	Whether a proposed use is permitted and under what conditions	Uses the committee cannot resolve

The map places the vendor request with the governance committee, not with business development, because it involves a new purpose and a party outside the organization.

Access Tiers

Access to the joined data should be tiered. The first tier is identified operational use: monitoring nurses and clinicians viewing a patient's readings and record to care for that patient. The second is limited internal analysis: the quality team using identified or partly identified data to evaluate the monitoring program. The third is de-identified research or development, which requires review of the method used to de-identify and the purpose.

The vendor sits in none of these by default. It is not caring for patients, it is not the system's quality team and its purpose is commercial product development. That does not mean sharing is impossible, but it means the request must be treated as a new category, with its own conditions, rather than fitted into an existing one.

Consent and Transparency

Patients enrolled in remote monitoring signed a consent that described the program's purpose: to allow nurses to watch their readings and respond to changes. It said the data would be stored in the health system's records. It did not mention use for developing commercial products or sharing with outside companies. Whether the law requires consent for a de-identified extract is one question; whether patients would feel their trust was respected is another.

Price and Cohen (2019) argue that health privacy law focuses on who holds data and how it moves, and that de-identification alone does not address all the ways medical big data can harm people, including loss of trust. For a monitoring program that depends on patients sending readings every day, trust is not abstract. If patients learned from a news story that their daily weights were used to build a commercial product, some might stop sending them. The analysis therefore recommends that, whatever the legal answer, the system disclose secondary uses in future enrollment materials and consider a notice to current patients.

What this page is doingThe paper separates what the law permits from what patients were told, which is where stewardship questions usually sit.

What the Law Requires, and What It Leaves Open

Under the HIPAA Privacy Rule, a covered entity has two routes to de-identified data (Other Requirements Relating to Uses and Disclosures of Protected Health Information, 45 C.F.R. § 164.514, 2024). The safe harbor method removes a list of specified identifiers, including names, most geographic detail smaller than a state and most elements of dates other than year. The expert determination method requires a qualified expert to conclude that the chance of anyone being identified is very low, given the data and the context of release.

For this extract, safe harbor is hard to meet in a useful form. A deterioration model depends on the timing of readings relative to admissions, and removing dates destroys that. Expert determination is more likely, but it depends on the expert's judgment about context, including what else the vendor holds. Research on re-identification has shown that individuals can often be re-identified from a small number of demographic attributes, even in incomplete data sets (Rocher et al., 2019). Daily physiological readings over two years are highly distinctive. Meeting either legal pathway is therefore a floor, not a guarantee, and the system's contract should prohibit re-identification attempts, limit linkage to other data and allow audit.

Accountability for Model Error

The most neglected question is who answers when the model is wrong. If the system later licenses the model and a patient deteriorates at home without being flagged, the vendor will point to the data it was trained on, and the system will point to the vendor's model. Before sharing data, the executive team should settle three things. The system must be able to validate the model on its own patients before using it, including performance in subgroups such as older adults and patients with limited English. Nurses must keep the authority to act on their own judgment, whatever the model's score. And the contract should state who is responsible for monitoring the model's performance after deployment and for reporting when it drifts.

Recommendation for the Executive Team

The analysis recommends that the executive team not approve the extract on the vendor's current terms. It should first adopt the stewardship map, route the request through the governance committee and require expert determination of de-identification with contractual limits on linkage and re-identification. It should also update enrollment materials for future patients, and secure rights to local validation and shared accountability for model error. If the vendor accepts those terms, the extract may be a reasonable contribution to a tool that could help patients. If it does not, the discount is not worth the data.

References

Khatri, V., & Brown, C. V. (2010). Designing data governance. Communications of the ACM, 53(1), 148-152. https://doi.org/10.1145/1629175.1629210

Other Requirements Relating to Uses and Disclosures of Protected Health Information, 45 C.F.R. § 164.514 (2024).

Price, W. N., II, & Cohen, I. G. (2019). Privacy in the age of medical big data. Nature Medicine, 25(1), 37-43. https://doi.org/10.1038/s41591-018-0272-7

Rocher, L., Hendrickx, J. M., & de Montjoye, Y.-A. (2019). Estimating the success of re-identifications in incomplete datasets using generative models. Nature Communications, 10(1), Article 3069. https://doi.org/10.1038/s41467-019-10933-3

NURS 8210 Week 7 instructions, in plain terms

The stewardship assignment generally has you examine a data use decision in your organization and set out who may decide, under what rules and with what accountability. Submissions usually run several APA pages and include a roles table. Frame the decision precisely, including what data are involved and who is asking. Distinguish decision rights from technical custody. Define access tiers and place the request among them. Examine consent and transparency separately from legal requirements. Explain the relevant legal standard accurately without offering legal advice. Address who is accountable if a product built on the data causes harm. Finish with a recommendation to the executive team.

How the NURS 8210 Week 7 example is put together

The first section describes the vendor's request and the executive decision. A stewardship section cites Khatri and Brown and notes that nobody owns the joined data set. Table 1 assigns executive owner, steward, custodian and privacy review, with what each may decide alone. An access section defines three tiers. A consent section notes that enrollment forms said nothing about commercial use and cites Price and Cohen on trust. A legal section explains safe harbor and expert determination, notes that removing dates would ruin the model and cites Rocher and colleagues. A section on model error requires local validation and nurse override. The recommendation declines the vendor's current terms.

Where the marks sit in the NURS 8210 Week 7 rubric

Stewardship papers are typically graded on clarity of the decision, a defensible roles structure, accurate treatment of consent and law, and attention to accountability. Decision clarity rewards a precise account of the data and the request. Roles credit depends on distinguishing decision rights from custody and assigning them to positions. Legal accuracy is essential, and papers are credited for explaining standards without overstating them. Consent and transparency earn credit when treated as ethical questions beyond compliance. Accountability for downstream harm is often the most distinctive element. The roles table, referencing and source quality account for the remaining points. Faculty mark down papers that treat de-identification as the end of the analysis.

NURS 8210 Week 7 help: mistakes that cost marks

Stewardship papers lose marks when they summarize HIPAA and stop. Another common loss is assigning data ownership to the information technology department by default. Some papers ignore what patients were told when they enrolled. Others never ask who answers if a model built on the data fails. Frame the decision, map roles, set tiers, separate ethics from law, explain de-identification accurately and assign accountability. The desk can draft an analysis of a data request your organization is weighing. Read your organization's enrollment and consent forms before writing, since the answer to the transparency question usually starts there. Talk with your privacy officer about how similar requests were handled before, since precedent often shapes what the organization will accept.

Get a NURS 8210 Week 7 example written to your instructions

The decision a governance prompt poses varies, a vendor extract, a research request or an analytics platform, so include that decision alongside the rubric. A custom analysis follows within 24-48h, the first free, with the stewardship map in an editable table and every legal reference checked against its source.

More NURS 8210 papers and DNP samples

NURS 8210 Week 7 questions, answered

Is this legal advice about sharing health data?

No, and the analysis says as much. It describes what the HIPAA Privacy Rule's de-identification pathways are and argues about governance and ethics, but any real data-sharing decision needs the organization's privacy officer and counsel. The paper recommends involving them explicitly, which is also what doctoral graders expect from a leader who knows where their own authority ends.

Where can I find a free NURS 8210 Week 7 sample paper?

The full stewardship analysis, with its roles table, access tiers and legal and ethical sections, is free to read here. An analysis of a data request in your own organization can be requested.

What does the NURS 8210 Week 7 paper recommend about the vendor request?

Not to approve it on current terms. The system should adopt the stewardship map, require expert de-identification with contractual limits, update enrollment materials and secure local validation and shared accountability first.

Why is safe harbor de-identification hard for this extract?

A deterioration model depends on timing of readings relative to admissions, and safe harbor removes most date elements, which would strip that timing out.

Who answers if the vendor's model is wrong?

The paper asks leaders to settle this before sharing: local validation rights, nurse authority to act on judgment and a contract naming who monitors performance after deployment.